Engineered neuroprotective stem-cell exosomes for in utero spina bifida therapy
用于子宫内脊柱裂治疗的工程神经保护干细胞外泌体
基本信息
- 批准号:10271311
- 负责人:
- 金额:$ 48.99万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-30 至 2025-08-31
- 项目状态:未结题
- 来源:
- 关键词:AchievementAnimal ModelAnimalsBindingBiocompatible MaterialsBiomedical EngineeringBirthBladder DysfunctionBone DiseasesBone RegenerationCaringCell CommunicationCellsChemical InjuryChildChildhoodClinicalClinical TrialsCollagenDefectDeformityDiseaseEngineeringEnvironmentExposure toFetal DevelopmentFetal SheepFetal TissuesGlycolic-Lactic Acid PolyesterGoalsGoldGrowthHealth Care CostsHumanHydrogelsHydroxyapatitesImmobilizationIn VitroIntestinesKyphosis deformity of spineLifeLimb structureLongevityMechanicsMeningomyeloceleMesenchymalMethodsModelingMolecularMolecular WeightMorbidity - disease rateMotorMuscleMusculoskeletalNeural Tube ClosureNeurodegenerative DisordersOperative Surgical ProceduresOryctolagus cuniculusOsteogenesisOutcomeParalysedPatientsPeptidesPhysical therapyPlayPreventive careQuality of lifeRecovery of FunctionRegimenRodentRoleSpeedSpinal CordSpinal DysraphismSpinal cord injuryStructureSurfaceSystemTestingTherapeuticTherapeutic UsesTransplantationTraumaUnited StatesUnited States National Institutes of HealthVertebral columnWalkingbasebiodegradable polymerbioscaffoldbonecognitive disabilitydensitydesigndosageexosomeexperimental studyextracellular vesiclesfetalfunctional grouphindbrainimprovedin uteroin vivoindependent ambulationmechanical propertiesneuroprotectionnovelnovel strategiesnovel therapeuticsparacrinepostnatalpre-clinicalprenatal therapypreventregeneration functionregeneration potentialregenerativeregenerative therapyrepairedscaffoldsheep modelspinal cord compressionstandard of carestem cell exosomesstem cells
项目摘要
ABSTRACT
Myelomeningocele (MMC) is the most severe form of spina bifida (SB) and the most common congenital cause
of lifelong paralysis in the United States, where approximately four children are born daily with this devastating
disease. MMC results from the incomplete closure of the neural tube and absent overlying spine leaving the
spinal cord exposed to intrauterine mechanical and chemical trauma. This trauma results in lifelong paralysis,
bowel and bladder dysfunction, musculoskeletal deformities, and cognitive disabilities due to hindbrain
herniation. In utero surgical repair improves morbidity, but functional recovery is incomplete and the majority of
children are still unable to walk independently. We developed a treatment for MMC that augments the standard
of care, in utero MMC surgical repair, with placental mesenchymal stromal/stem cells (PMSCs). We found that
treatment with PMSCs, during in utero repair, prevents hind limb paralysis in the well-established fetal ovine
model of MMC, due to PMSC paracrine secretion of neuroprotective factors. However, we confirmed that PMSCs
did not engraft long-term and treated lambs developed severe kyphosis causing spinal cord compression and
tethering due to the lack of bone and adjacent paraspinal muscles, which is consistent with human MMC
musculoskeletal deformities. To meet this need for a long-lasting therapy for MMC, we explored the use of
bioengineered multifunctional combination scaffolds. Exosomes are extracellular vesicles that play significant
roles in cell-to cell communication. We confirmed that exosomes secreted by PMSCs (PMSC-exosomes) exert
significant neuroprotective functions, similar in magnitude to the live PMSCs from which they are derived. In this
study, we propose to develop an engineered hydrogel system that will allow for both local and sustained release
of PMSC-exosomes to the spinal cord, which in turn will provide sustained neuroprotection to treat MMC before
birth. In addition, we aim to increase the longevity of the in utero treatment by covering the defect with a
biomaterial-based bony scaffold to provide structural and functional support. We plan to optimize the
neuroprotective and regenerative functions of the bioscaffold using our well-established fetal rodent and rabbit
models of MMC. We will evaluate the final combination multifunctional bioscaffold product in our gold-standard
fetal ovine model of MMC. This therapeutic will be cell-free, off-the-shelf, and easy-to-use. If successful, this
novel approach will be used to treat MMC before birth, and due to its regenerative qualities, the treatment will
improve the quality of life of these patients, as well as significantly lower the healthcare costs associated with
the current treatment.
抽象的
脊髓脊膜膨出 (MMC) 是脊柱裂 (SB) 最严重的形式,也是最常见的先天性病因
在美国,每天大约有四个孩子出生时患有这种毁灭性的终身瘫痪
疾病。 MMC 是由神经管不完全闭合和上覆脊柱缺失导致的
脊髓暴露于宫内机械和化学损伤。这种创伤导致终身瘫痪
肠和膀胱功能障碍、肌肉骨骼畸形以及后脑引起的认知障碍
疝气。子宫内手术修复可改善发病率,但功能恢复不完全,并且大多数
孩子们仍然无法独立行走。我们开发了一种 MMC 治疗方法,可提高标准
护理,使用胎盘间充质基质/干细胞 (PMSC) 进行子宫内 MMC 手术修复。我们发现
在子宫内修复过程中使用 PMSC 进行治疗可预防已成熟的胎羊的后肢瘫痪
MMC模型,由于PMSC旁分泌神经保护因子。然而,我们证实 PMSC
没有长期移植,经过治疗的羔羊出现严重的后凸畸形,导致脊髓受压
由于缺乏骨骼和邻近的椎旁肌肉而导致束缚,这与人类 MMC 一致
肌肉骨骼畸形。为了满足 MMC 长期治疗的需求,我们探索了使用
生物工程多功能组合支架。外泌体是发挥重要作用的细胞外囊泡
在细胞间通讯中发挥作用。我们证实 PMSC 分泌的外泌体(PMSC-exosome)发挥
显着的神经保护功能,其强度与它们来源的活 PMSC 相似。在这个
研究中,我们建议开发一种工程水凝胶系统,该系统将允许局部和持续释放
的 PMSC-外泌体到脊髓,这反过来将为治疗 MMC 提供持续的神经保护
出生。此外,我们的目标是通过用覆盖物覆盖缺陷来延长子宫内治疗的寿命。
基于生物材料的骨支架提供结构和功能支持。我们计划优化
使用我们成熟的胎儿啮齿动物和兔子的生物支架的神经保护和再生功能
MMC 模型。我们将按照我们的黄金标准评估最终组合的多功能生物支架产品
MMC胎羊模型。这种疗法是无细胞的、现成的且易于使用。如果成功的话,这
新方法将用于在出生前治疗 MMC,并且由于其再生特性,该治疗将
改善这些患者的生活质量,并显着降低与相关的医疗费用
目前的治疗。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Diana Lee Farmer其他文献
Antibiotics alone versus appendicectomy for uncomplicated appendicitis in children
单纯使用抗生素与阑尾切除术治疗儿童单纯性阑尾炎的比较
- DOI:
10.1016/s0140-6736(25)00096-0 - 发表时间:
2025-01-18 - 期刊:
- 影响因子:88.500
- 作者:
Diana Lee Farmer - 通讯作者:
Diana Lee Farmer
Continuous Transabdominal Fetal Pulse Oximetry (TFO) in Pregnant Ewe Models under Induced Fetal Hypoxia
诱导胎儿缺氧下怀孕母羊模型的连续经腹胎儿脉搏血氧饱和度 (TFO)
- DOI:
- 发表时间:
2023 - 期刊:
- 影响因子:9.8
- 作者:
Weitai Qian;Kourosh Vali;Begum Kasap;C. Pivetti;Christina M. Theodorou;E. Kulubya;Kaeli J. Yamashiro;Aijun Wang;H. Hedriana;Diana Lee Farmer;S. Ghiasi - 通讯作者:
S. Ghiasi
Thrombocytopenia in Pediatric Oncology Patients: A Good Reason to Delay Central Venous Catheter Insertion?
- DOI:
10.1016/j.jamcollsurg.2020.07.777 - 发表时间:
2020-10-01 - 期刊:
- 影响因子:
- 作者:
Sarah C. Stokes;Kaeli J. Yamashiro;Jordan E. Jackson;Christina M. Theodorou;Diana Lee Farmer;Shinjiro Hirose;Payam Saadai;Alana L. Beres;Erin M.D. Brown - 通讯作者:
Erin M.D. Brown
Diana Lee Farmer的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Diana Lee Farmer', 18)}}的其他基金
Engineered Neuroprotective Stem-Cell Exosomes for In Utero Spina Bifida Therapy
用于子宫内脊柱裂治疗的工程神经保护干细胞外泌体
- 批准号:
10705047 - 财政年份:2020
- 资助金额:
$ 48.99万 - 项目类别:
Validation of Transabdominal Fetal Pulse Oximetry in Hypoxic Fetal Lamb Models
经腹胎儿脉搏血氧饱和度在缺氧胎儿羔羊模型中的验证
- 批准号:
10057202 - 财政年份:2020
- 资助金额:
$ 48.99万 - 项目类别:
Validation of Transabdominal Fetal Pulse Oximetry in Hypoxic Fetal Lamb Models
经腹胎儿脉搏血氧饱和度在缺氧胎儿羔羊模型中的验证
- 批准号:
10214652 - 财政年份:2020
- 资助金额:
$ 48.99万 - 项目类别:
MULTICENTER TRIAL OF FETAL MYELOMENINGOCELE REPAIR
胎儿脊髓脊膜膨出修复的多中心试验
- 批准号:
7940506 - 财政年份:2002
- 资助金额:
$ 48.99万 - 项目类别:
MULTICENTER TRIAL OF FETAL MYELOMENINGOCELE REPAIR
胎儿脊髓脊膜膨出修复的多中心试验
- 批准号:
7567854 - 财政年份:2002
- 资助金额:
$ 48.99万 - 项目类别:
相似海外基金
Quantification of Neurovasculature Changes in a Post-Hemorrhagic Stroke Animal-Model
出血性中风后动物模型中神经血管变化的量化
- 批准号:
495434 - 财政年份:2023
- 资助金额:
$ 48.99万 - 项目类别:
Bioactive Injectable Cell Scaffold for Meniscus Injury Repair in a Large Animal Model
用于大型动物模型半月板损伤修复的生物活性可注射细胞支架
- 批准号:
10586596 - 财政年份:2023
- 资助金额:
$ 48.99万 - 项目类别:
A Comparison of Treatment Strategies for Recovery of Swallow and Swallow-Respiratory Coupling Following a Prolonged Liquid Diet in a Young Animal Model
幼年动物模型中长期流质饮食后吞咽恢复和吞咽呼吸耦合治疗策略的比较
- 批准号:
10590479 - 财政年份:2023
- 资助金额:
$ 48.99万 - 项目类别:
Small animal model for evaluating the impacts of cleft lip repairing scar on craniofacial growth and development
评价唇裂修复疤痕对颅面生长发育影响的小动物模型
- 批准号:
10642519 - 财政年份:2023
- 资助金额:
$ 48.99万 - 项目类别:
Diurnal grass rats as a novel animal model of seasonal affective disorder
昼夜草鼠作为季节性情感障碍的新型动物模型
- 批准号:
23K06011 - 财政年份:2023
- 资助金额:
$ 48.99万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Longitudinal Ocular Changes in Naturally Occurring Glaucoma Animal Model
自然发生的青光眼动物模型的纵向眼部变化
- 批准号:
10682117 - 财政年份:2023
- 资助金额:
$ 48.99万 - 项目类别:
A whole animal model for investigation of ingested nanoplastic mixtures and effects on genomic integrity and health
用于研究摄入的纳米塑料混合物及其对基因组完整性和健康影响的整体动物模型
- 批准号:
10708517 - 财政年份:2023
- 资助金额:
$ 48.99万 - 项目类别:
A Novel Large Animal Model for Studying the Developmental Potential and Function of LGR5 Stem Cells in Vivo and in Vitro
用于研究 LGR5 干细胞体内外发育潜力和功能的新型大型动物模型
- 批准号:
10575566 - 财政年份:2023
- 资助金额:
$ 48.99万 - 项目类别:
Elucidating the pathogenesis of a novel animal model mimicking chronic entrapment neuropathy
阐明模拟慢性卡压性神经病的新型动物模型的发病机制
- 批准号:
23K15696 - 财政年份:2023
- 资助金额:
$ 48.99万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
The effect of anti-oxidant on swallowing function in an animal model of dysphagia
抗氧化剂对吞咽困难动物模型吞咽功能的影响
- 批准号:
23K15867 - 财政年份:2023
- 资助金额:
$ 48.99万 - 项目类别:
Grant-in-Aid for Early-Career Scientists